Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 25, 2018

SELL
$97.82 - $116.09 $369,368 - $438,355
-3,776 Closed
0 $0
Q2 2018

Aug 02, 2018

SELL
$97.62 - $120.59 $664,401 - $820,735
-6,806 Reduced 64.32%
3,776 $437,000
Q1 2018

Apr 23, 2018

BUY
$95.91 - $107.26 $393,231 - $439,766
4,100 Added 63.25%
10,582 $1.05 Million
Q4 2017

Feb 08, 2018

BUY
$104.5 - $126.38 $677,369 - $819,195
6,482
6,482 $679,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.